Guidelines for the Management of ANCA-Associated Vasculitis v1.2
Preview
Overview
The objective of this document is to provide guidance for the treatment of ANCA-associated vasculitis with renal involvement. These guidelines may also be followed in other forms of crescentic nephritis due to vasculitis e.g. Henoch-Schönlein Purpura crescentic IgA nephropathy although the evidence base in these situations is less secure.
Categories
ClinicalReference
Date Uploaded
24.08.2021Date Review
23.08.2024File Size
371KbClinical Guidelines
This guideline has been approved by the Trust's Clinical Guidelines Assessment Panel as an aid to the diagnosis and management of relevant patients and clinical circumstances. Not every patient or situation fits neatly into a standard guideline scenario and the guideline must be interpreted and applied in practice in the light of prevailing clinical circumstances, the diagnostic and treatment options available and the professional judgement, knowledge and expertise of relevant clinicians. It is advised that the rationale for any departure from relevant guidance should be documented in the patient's case notes.The Trust's guidelines are made publicly available as part of the collective endeavour to continuously improve the quality of healthcare through sharing medical experience and knowledge. The Trust accepts no responsibility for any misunderstanding or misapplication of this document.